206 related articles for article (PubMed ID: 37287359)
1. [Paraneoplastic Neurologic Syndromes].
Tanaka K
Brain Nerve; 2023 Jun; 75(6):755-762. PubMed ID: 37287359
[TBL] [Abstract][Full Text] [Related]
2. Update on paraneoplastic neurological syndromes.
Didelot A; Honnorat J
Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
5. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
8. Paraneoplastic antibodies targeting intracellular antigens.
Linnoila JJ
Handb Clin Neurol; 2024; 200():335-346. PubMed ID: 38494288
[TBL] [Abstract][Full Text] [Related]
9. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
10. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
Stich O; Rauer S
Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
[TBL] [Abstract][Full Text] [Related]
12. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic disorders of the central and peripheral nervous systems.
Didelot A; Honnorat J
Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic neurologic syndromes. Diagnostic and pathogenetic significance of autoantibodies].
Kaiser R
Nervenarzt; 1999 Aug; 70(8):688-701. PubMed ID: 10483569
[TBL] [Abstract][Full Text] [Related]
17. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
19. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
